Compare Mutual Funds

Pros

-

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
-
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

4 Years 8 Months

13 Years 8 Months

Fund AUM

₹238 Cr

₹8636 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.68%

0.79%

Exit Load

0.5%

1%

Benchmark Index

Nifty Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

41

37

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.4%)
  2. Divi's Laboratories Ltd(8.83%)
  3. Apollo Hospitals Enterprise Ltd(6.25%)
  4. Max Healthcare Institute Ltd Ordinary Shares(5.22%)
  5. Torrent Pharmaceuticals Ltd(4.82%)
  1. Sun Pharmaceuticals Industries Ltd(13.35%)
  2. Lupin Ltd(7.31%)
  3. Dr Reddy's Laboratories Ltd(6.72%)
  4. Cipla Ltd(6.16%)
  5. Divi's Laboratories Ltd(5.8%)
No of Sectors

4

1

Top 3 Sectors
  1. Health(93.7%)
  2. Basic Materials(4.06%)
  3. Financial Services(1.3%)

Health

(100%)

Equity %

98.25%

97.92%

Debt %

-

-

P/E

41.02

36.71

P/B

5.62

5.41

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

6.79%

5.9%

3-Month Return

19.99%

16.47%

6-Month Return

11.71%

9.38%

1-Year Return

7.62%

9.02%

3-Year Return

21.66%

21.97%

5-Year Return

-

13.95%

Sharpe

0.88

0.97

Alpha

-0.14

-0.78

Beta

0.94

0.89

Standard Deviation

16.61

15.23

Information Ratio

-0.23

-0.76

Description

ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Animesh Singh, Nilay Dalal

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons